SCHEMBL30423773

SCHEMBL30423773

Clc1ccnc2c(I)n[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ PLK3 Q9H4B4 1/20 0.39
▸ DAO P14920 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ TDP1 Q9NUW8 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HSP90AA1 P07900 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ ALOX12 P18054 2/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ OPRK1 P41145 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ MMP14 P50281 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25257294 1.00 CHEK1 (0.39) CHEK1FLT3PLK3DAOKDM4E
SCHEMBL3465338 0.77 DAO (0.38) CHEK1FLT3PLK3DAOKDM4E
SCHEMBL16593421 0.71 KDM5A (0.45) CHEK1DAOKDM4EMEN1ALDH1A1
SCHEMBL1944275 0.69 LRRK2 (0.41) CHEK1DAOAXLPRKCI
SCHEMBL18529490 0.69 DYRK1A (0.36) CHEK1FLT3PLK3LMNACYP3A4
SCHEMBL30406172 0.69 LRRK2 (0.41) CHEK1DAOAXLPRKCI
SCHEMBL29760851 0.69 DYRK1A (0.36) CHEK1FLT3PLK3LMNACYP3A4
SCHEMBL15866141 0.68 CHEK1 (0.66) CHEK1FLT3PLK3DAOCYP1A2
SCHEMBL30040295 0.68 CHEK1 (0.66) CHEK1FLT3PLK3DAOCYP1A2
SCHEMBL19997517 0.68 DAO (0.41) DAOKDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120058798-A Bicyclic TEAD inhibitors 武汉人福创新药物研发中心有限公司 2025-05-30 — — CN disclosed
EP-4436957-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Genentech, Inc. (US) 2024-10-02 — — EP disclosed
CN-118302411-A Therapeutic indazole compounds and methods of use thereof for the treatment of cancer 基因泰克公司 2024-07-05 — — CN disclosed
WO-2023097195-A1 THERAPEUTIC INDAZOLE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER GENENTECH, INC. (US) 2023-06-01 — — WO disclosed
Send feedback